2004
Cities and Health: History, Approaches, and Key Questions
Vlahov D, Gibble E, Freudenberg N, Galea S. Cities and Health: History, Approaches, and Key Questions. Academic Medicine 2004, 79: 1133-1138. PMID: 15563646, DOI: 10.1097/00001888-200412000-00003.ChaptersTelevision Images and Probable Posttraumatic Stress Disorder After September 11
Ahern J, Galea S, Resnick H, Vlahov D. Television Images and Probable Posttraumatic Stress Disorder After September 11. The Journal Of Nervous And Mental Disease 2004, 192: 217-226. PMID: 15091303, DOI: 10.1097/01.nmd.0000116465.99830.ca.Peer-Reviewed Original Research
2002
DRUG USER TREATMENT REFERRALS AND ENTRY AMONG PARTICIPANTS OF A NEEDLE EXCHANGE PROGRAM
Riley E, Safaeian M, Strathdee S, Brooner R, Beilenson P, Vlahov D. DRUG USER TREATMENT REFERRALS AND ENTRY AMONG PARTICIPANTS OF A NEEDLE EXCHANGE PROGRAM. Substance Use & Misuse 2002, 37: 1869-1886. PMID: 12511056, DOI: 10.1081/ja-120014088.Peer-Reviewed Original ResearchConceptsNEP participantsNeedle exchange programsTreatment referralMethadone treatmentMultiple logistic regression modelUse of speedballsDrug user treatmentNeedle exchange program participantsLogistic regression modelsMedian ageMethadone maintenanceOdds ratioFemale genderFirst injectionDrug useTreatment entryReferral
1999
Compliance With Universal Precautions in Correctional Health Care Facilities
Gershon R, Karkashian C, Vlahov D, Kummer L, Kasting C, Green-McKenzie J, Escamilla-Cejudo J, Kendig N, Swetz A, Martin L. Compliance With Universal Precautions in Correctional Health Care Facilities. Journal Of Occupational And Environmental Medicine 1999, 41: 181-189. PMID: 10091141, DOI: 10.1097/00043764-199903000-00007.Peer-Reviewed Original ResearchConceptsHealth care workersBloodborne exposuresUniversal precautionsCare workersCompliance rateCorrectional health care workersCorrectional health-care facilitiesBody fluid exposuresCross-sectional studyHealth care facilitiesPersonal protective equipmentCorrelates of complianceSharps disposalModifiable correlatesProtective eyewearInterventional strategiesFluid exposureCare facilitiesOverall complianceProtective equipmentCompliance ScaleFace maskAdverse working conditionsDemographic factorsExposure
1998
Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users
Garfein R, Doherty M, Monterroso E, Thomas D, Nelson K, Vlahov D. Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s11-s19. PMID: 9663618, DOI: 10.1097/00042560-199802001-00004.Peer-Reviewed Original ResearchConceptsYoung adult injection drug usersAdult injection drug usersInjection drug usersHepatitis C virus infectionC virus infectionHCV infectionVirus infectionDrug usersHCV-seronegative participantsTransmission of HCVCommunity-based outreachSecond-generation antibodiesHCV seroconversionHCV seroprevalenceCommunity outreach educationProspective studyRisk factorsSemiannual interviewsHigh riskInjecting practicesSterile syringesBivariate analysisLogistic regressionInfectionHCV
1992
Knowledge of Therapeutics for Human Immunodeficiency Virus Infection among Intravenous Drug Users
Smith M, Celentano D, Solomon L, Astemborski J, Vlahov D. Knowledge of Therapeutics for Human Immunodeficiency Virus Infection among Intravenous Drug Users. The Journal Of Infectious Diseases 1992, 166: 685-686. PMID: 1500759, DOI: 10.1093/infdis/166.3.685.Peer-Reviewed Original ResearchPrognostic indicators for development of AIDS among intravenous drug users.
Muñoz A, Vlahov D, Solomon L, Margolick J, Bareta J, Cohn S, Astemborski J, Nelson K. Prognostic indicators for development of AIDS among intravenous drug users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 694-700. PMID: 1613668.Peer-Reviewed Original ResearchConceptsCD4 cell countIntravenous drug usersClinical symptomsDrug usersCell countHigher CD4 cell countsHIV-1-related symptomsSeropositive intravenous drug usersPneumocystis carinii prophylaxisIntravenous drug useDevelopment of AIDSDose-response relationshipYear of enrollmentSerum neopterinLaboratory markersSerum betaPrognostic indicatorClinical evaluationAntiviral agentsRelative hazardDrug useSurvival analysisMultivariate analysisSignificant associationAIDS